HARVARD BIOSCIENCE INC (HBIO) Forecast, Price Target & Analyst Ratings

NASDAQ:HBIO • US4169061052

Current stock price

5.27 USD
-0.33 (-5.89%)
At close:
5.26 USD
-0.01 (-0.19%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HARVARD BIOSCIENCE INC (HBIO).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
21.624M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $5.27 to mean target of N/A, Based on 8 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HBIO Current Analyst RatingHBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

HBIO Historical Analyst RatingsHBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
HBIO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HBIO.
In the previous month the buy percentage consensus was at a similar level.
HBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16BenchmarkMaintains Speculative Buy -> Speculative Buy
2026-03-13BenchmarkMaintains Speculative Buy -> Speculative Buy
2025-09-10BenchmarkMaintains Speculative Buy -> Speculative Buy
2025-05-13BenchmarkMaintains Speculative Buy -> Speculative Buy
2025-04-09KeybancDowngrade Overweight -> Sector Weight
2025-04-08KeybancDowngrade Overweight -> Sector Weight
2025-03-24BenchmarkMaintains Speculative Buy -> Speculative Buy
2023-06-22BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-04-26KeybancMaintains Overweight
2023-04-26BenchmarkMaintains Buy
2023-03-10BenchmarkReiterate Buy
2022-11-09KeybancMaintains Overweight
2022-08-05KeybancMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
21.624M
Revenue Q2Q
-0.69%
EPS Q2Q
49.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
-0.24%
Revenue (3 Months)
-0.24%
EPS (1 Month)
-900.00%
EPS (3 Months)
-900.00%

Next Earnings Summary

HBIO is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 21.62M USD.
The next earnings revenue estimate has been revised downward by 0.24% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
HBIO revenue by date.HBIO revenue by date.
112.25M
-0.93%		94.135M
-16.14%		86.55M
-8.06%		91.188M
5.36%		98.43M
7.94%
EBITDA
YoY % growth
HBIO ebitda by date.HBIO ebitda by date.
9.283M
223.45%		1.781M
-80.81%		5.486M
208.03%		12.597M
129.62%		14.892M
18.22%
EBIT
YoY % growth
HBIO ebit by date.HBIO ebit by date.
2.285M
148.62%		-5.376M
-335.27%		-459K
91.46%		-408K
11.11%		7.242M
1,875.00%
Operating Margin
HBIO operating margin by date.HBIO operating margin by date.
2.04%-5.71%-0.53%-0.45%7.36%
EPS
YoY % growth
HBIO eps by date.HBIO eps by date.
1.50
25.00%		0.60
-60.00%		-0.20
-133.33%		0.97
584.50%		2.04
110.53%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.05
49.00%		0.31
406.00%		0.310.41
Revenue
Q2Q % growth		21.624M
-0.69%		22.338M
9.23%		22.338M
8.48%		24.888M
4.86%
EBITDA
Q2Q % growth		1.326M
4,177.42%		2.142M
-13.70%		2.499M
-48.37%		3.825M
-50.03%
EBIT
Q2Q % growth		-765K
52.89%		918K
216.35%		1.326M
441.22%		2.295M
34.29%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HBIO Yearly Revenue VS EstimatesHBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
HBIO Yearly EPS VS EstimatesHBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HARVARD BIOSCIENCE INC / HBIO Forecast FAQ

When does HARVARD BIOSCIENCE INC (HBIO) report earnings?

HARVARD BIOSCIENCE INC (HBIO) will report earnings on 2026-05-11.

Can you provide the consensus estimates for HARVARD BIOSCIENCE INC next earnings?

The consensus EPS estimate for the next earnings of HARVARD BIOSCIENCE INC (HBIO) is -0.05 USD and the consensus revenue estimate is 21.62M USD.

Can you provide the consensus rating for HARVARD BIOSCIENCE INC stock?

The consensus rating for HARVARD BIOSCIENCE INC (HBIO) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.